- Home
- HKIT vs PDSB Comparison
HKIT vs PDSB Comparison
Compare HKIT & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- PDSB
- Stock Information
- Founded
- HKIT 1996
- PDSB 2005
- Country
- HKIT China
- PDSB United States
- Employees
- HKIT N/A
- PDSB N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- HKIT Technology
- PDSB Health Care
- Exchange
- HKIT Nasdaq
- PDSB Nasdaq
- Market Cap
- HKIT 54.8M
- PDSB 44.5M
- IPO Year
- HKIT 2023
- PDSB N/A
- Fundamental
- Price
- HKIT $1.89
- PDSB $0.93
- Analyst Decision
- HKIT
- PDSB Strong Buy
- Analyst Count
- HKIT 0
- PDSB 2
- Target Price
- HKIT N/A
- PDSB $10.00
- AVG Volume (30 Days)
- HKIT 15.6K
- PDSB 470.8K
- Earning Date
- HKIT 10-31-2025
- PDSB 11-13-2025
- Dividend Yield
- HKIT N/A
- PDSB N/A
- EPS Growth
- HKIT N/A
- PDSB N/A
- EPS
- HKIT N/A
- PDSB N/A
- Revenue
- HKIT $2,904,950.00
- PDSB N/A
- Revenue This Year
- HKIT N/A
- PDSB N/A
- Revenue Next Year
- HKIT N/A
- PDSB N/A
- P/E Ratio
- HKIT N/A
- PDSB N/A
- Revenue Growth
- HKIT N/A
- PDSB N/A
- 52 Week Low
- HKIT $1.15
- PDSB $0.85
- 52 Week High
- HKIT $2.08
- PDSB $3.48
- Technical
- Relative Strength Index (RSI)
- HKIT 60.04
- PDSB 35.69
- Support Level
- HKIT $1.80
- PDSB $0.90
- Resistance Level
- HKIT $2.05
- PDSB $1.02
- Average True Range (ATR)
- HKIT 0.08
- PDSB 0.06
- MACD
- HKIT -0.01
- PDSB 0.00
- Stochastic Oscillator
- HKIT 44.83
- PDSB 20.56
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.